Filing metadata

Accession number
0001641172-25-003093
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Apr 07, 2025
Reporting period
Apr 04, 2025
Description
Insider transaction

Explore SEC Filings Hub